John Baumstark
Ori Eisen
Tiff Macklem
Janet Perna
Michael Hyatt
Michael Hyatt is a serial entrepreneur and active investor. He is the co-founder of BlueCat, (acquired by Madison Dearborn Partners of Chicago, IL), and previously co-founded Dyadem, (acquired by IHS – NYSE: IHS). He currently serves as a Director of BlueCat, ranks as one of Canada’s top entrepreneurs, and is known as a technology visionary. Michael is also a weekly business commentator on CBC, is the Host of “Unplanned Business”, a podcast to help small businesses, and an investor on the hit Spotify podcast “The Pitch”. He is also a Founding Partner at the Rotman School of Management’s prestigious Creative Destruction Lab (CDL). Michael is an active investor and philanthropist…
Read MoreSwamy Kotagiri
Seetarama (Swamy) Kotagiri is Chief Executive Officer and a Director of Magna International. As CEO, Kotagiri is focused on keeping Magna at the forefront of a changing mobility landscape and accelerating the company’s growth for the benefit of employees, shareholders and customers. Kotagiri has more than 30 years of industry experience, including 21 with Magna. He has been instrumental in the company’s recent growth and evolution through his operational leadership, and has aligned the organization’s strategy around the megatrends shaping future mobility. Kotagiri has a master’s degree in mechanical engineering from Oklahoma State University with a specialization in materials and structural engineering. He has more than 12 patents in automotive…
Read MoreGab Goncalves
Gab Goncalves is a software entrepreneur and investor. He currently is an investor and the Executive Chairman of FieldRoutes, a cloud-based and mobile SaaS provider for field service businesses. The platform automates all aspects of field service operations for enterprise and small business customers that span back-office management, advanced route optimization, payment processing, digital sales, marketing, and customer acquisition solutions that accelerate growth, streamline operations, increase customer retention, and maximize revenue. Previously, Gab was a major investor and active board member in SignalPath, the premier clinical trial SaaS provider for research sites and sponsors, focused on improving the ease and efficiency of trial execution and management. Supporting over 2,500 clinical…
Read More